TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT02874404 · COMPLETED
Trial details
- NCT number
- NCT02874404
- Sponsor
- University of Nebraska
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-07
- Primary completion
- 2019-07-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.